Specializing in wearable sensor physiological monitoring solutions for clinical trials, healthcare research, and consumer wellness. Vivosense is developing regulatory compliant digital biomarkers using the data from wearable sensors. Digital biomarkers are used accurately to measure drug and treatment effects in patients in regulated clinical trials and healthcare research. Among the first analytics company to develop novel digital biomarkers from wearable sensor data, which constitute primary and secondary clinical endpoints in regulated international pharmaceutical trial, several of these studies are in rare disease indication and have reached the open-label phase of development at top-ten pharma. The hypothesis-driven framework provides analytical and clinical validation leading to FDA approval -- delivering novel digital biomarkers from wearable sensor data, which constitute primary and secondary clinical endpoints in regulated international pharmaceutical trials.
